Submitted by Anonymous (not verified) on 16 April 2024 - 15:37
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 23, Status: Authorised
Source: